Constitutional isomers of Reactive Blue 2 -: selective P2Y-receptor antagonists?

被引:45
作者
Glänzel, M
Bültmann, R
Starke, K
Frahm, AW
机构
[1] Chair Pharmaceut Chem, D-79104 Freiburg, Germany
[2] Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany
关键词
Reactive Blue 2; Cibacron Blue 3GA; P2-receptor antagonist; rat vas deferens; guinea-pig taenia coli; P2X(1)-receptor; P2Y(1)-like-receptor;
D O I
10.1016/S0223-5234(02)01449-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The anthraquinone derivative Reactive Blue 2 (RB 2) is one of the most widely used P2-receptor antagonists, still claimed to be P2Y-selective. RB 2 is defined as a mixture of two constitutional isomers and commercially available in different identity and purity. A sample of RB 2, offered for sale by RBI, purchased from Biotrend, Koln, Germany, was chromatographically purified and identified by H-1- and C-13-NMR studies as a 35:65 mixture of the terminal ring F meta and para constitutional isomers. The two constitutional isomers of RB 2 were synthesised and tested alongside with the ortho isomer Cibacron Blue 3GA (CB 3GA) on contractions of the,rat vas deferens (RVD) elicited by alpha,beta-methylene ATP (alpha,beta-MeATP), mediated by P2X(1)-receptors, and relaxations of the carbachol-precontracted guinea pig taenia coli elicited by adenosine 5'-O-(2-thiophosphate) (ADPOS), mediated by P2Y(1)-like-receptors. All compounds inhibited the alpha,beta-MeATP induced contraction of the RVD and the ADPbetaS induced relaxation of the carbachol precontracted guinea-pig taenia coli. The IC50-values at P2X(1)-R were 9.1 muM for CB 3GA, 28.4 muM for RB 2, 19.7 muM for RB 2 meta, and 35.5 muM for RB 2 para. The IC50-values at P2Y(1)-like-R were 17.4 muM for CB 3GA, 7.7 muM for RB 2, 12.0 muM for RB 2 meta, and 2.6 muM for RB 2 para. The results clearly show that neither RB 2 as a mixture nor the pure ortho and meta isomer are P2Y(1)-like- versus P2X(1)-selective antagonists. In contrast the pure para-isomer of RB 2 is a moderately P2Y(1)-like- versus P2X(1)-selective antagonist. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:303 / 312
页数:10
相关论文
共 40 条
[1]   COMPARATIVE-STUDIES ON THE AFFINITIES OF ATP DERIVATIVES FOR P-2X-PURINOCEPTORS IN RAT URINARY-BLADDER [J].
BO, XN ;
FISCHER, B ;
MAILLARD, M ;
JACOBSON, KA ;
BURNSTOCK, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (04) :1151-1159
[2]   A P2X PURINOCEPTOR CDNA CONFERRING A NOVEL PHARMACOLOGICAL PROFILE [J].
BO, XN ;
ZHANG, Y ;
NASSAR, M ;
BURNSTOCK, G ;
SCHOEPFER, R .
FEBS LETTERS, 1995, 375 (1-2) :129-133
[3]   NEW STRUCTURAL MOTIF FOR LIGAND-GATED ION CHANNELS DEFINED BY AN IONOTROPIC ATP RECEPTOR [J].
BRAKE, AJ ;
WAGENBACH, MJ ;
JULIUS, D .
NATURE, 1994, 371 (6497) :519-523
[4]  
BULTMANN R, 1995, N-S ARCH PHARMACOL, V352, P477
[5]  
BULTMANN R, 1994, N-S ARCH PHARMACOL, V349, P74
[6]   P-2-purinoceptor antagonists .3. Blockade of P-2-purinoceptor subtypes and ecto-nucleotidases by compounds related to suramin [J].
Bultmann, R ;
Wittenburg, H ;
Pause, B ;
Kurz, G ;
Nickel, P ;
Starke, K .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1996, 354 (04) :498-504
[7]   P-2-purinoceptor antagonists .1. Blockade of P-2-purinoceptor subtypes and ecto-nucleotidases by small aromatic isothiocyanato-sulphonates [J].
Bultmann, R ;
Pause, B ;
Wittenburg, H ;
Kurz, G ;
Starke, K .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1996, 354 (04) :481-490
[8]   Potential therapeutic targets in the rapidly expanding field of purinergic signalling [J].
Burnstock, G .
CLINICAL MEDICINE, 2002, 2 (01) :45-53
[9]  
Burnstock G, 2000, J PHARMACOL EXP THER, V295, P862
[10]   DESIGN AND APPLICATIONS OF BIOMIMETIC ANTHRAQUINONE DYES .1. SYNTHESIS AND CHARACTERIZATION OF TERMINAL RING ISOMERS OF CI REACTIVE BLUE-2 [J].
BURTON, SJ ;
MCLOUGHLIN, SB ;
STEAD, CV ;
LOWE, CR .
JOURNAL OF CHROMATOGRAPHY, 1988, 435 (01) :127-137